Injections of hyaluronic acid for the treatment of osteoarthritis (Ostenil, Synvisc) are not funded, in view of NICE guidance on the lack of cost-effectiveness.
They are funded for treatment of patients with pain from early chondral damage within the knee. An internal prior approval process is in place within UHCW.
(Visited 562 times, 1 visits today)

Leave feedback
You must be logged in to post a comment.